NewAmsterdam Pharma Company N.V. company logo
NewAmsterdam Pharma Company N.V. logo

NAMS Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$771.74M$431.29M+126.68%

Summary

Current Value
As of today, NAMS annual cash & cash equivalents is $771.74M, up +126.68% on
Historical Performance
NAMS annual cash & cash equivalents is up +1183.84% over the past 3 years, and up +7881.87% over the past 5 years
All-Time High Comparison
NAMS annual cash & cash equivalents is currently at its all-time high
3-Year Low Comparison
NAMS annual cash & cash equivalents is +126.68% above its 3-year low of $340.45M reached on
Sector Comparison
NAMS annual cash & cash equivalents is higher than 92.03% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NAMS Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$771.74M+126.7%+1183.8%+7881.9%+7881.9%
Quarterly Cash & Cash Equivalents$704.25M+66.6%+10000.0%+10000.0%+10000.0%
Price$35.80+40.1%+202.3%
Annual Current Assets$863.41M+149.0%+1195.3%+7514.6%+7514.6%
Annual Total Liabilities$107.12M+82.5%+1262.0%+763.3%+763.3%
Annual Working Capital$756.50M+154.8%+10000.0%+10000.0%+10000.0%
Annual Net Income-$241.60M-36.5%-5881.9%-10000.0%-10000.0%

Cash and Cash Equivalents Highs

NAMS Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$771.74Mat high
5Y$771.74Mat high
All$771.74Mat high

Cash and Cash Equivalents Lows

NAMS Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$340.45M+126.7%
5Y$9.67MN/A+7881.9%
All$9.67M+7881.9%

Cash and Cash Equivalents History

YearValueChange
$771.74M+126.7%
$340.45M-27.2%
$467.73M+678.1%
YearValueChange
$60.11M+521.7%
$9.67M-

FAQ

  • What is the current annual cash & cash equivalents of NAMS?

    As of today, NAMS annual cash & cash equivalents is $771.74M

  • What is 1-year change in NAMS annual cash & cash equivalents?

    NAMS annual cash & cash equivalents is up +126.68% year-over-year

  • What is 3-year change in NAMS annual cash & cash equivalents?

    NAMS annual cash & cash equivalents is up +1183.84% over the past 3 years

  • How far is NAMS annual cash & cash equivalents from its all-time high?

    NAMS annual cash & cash equivalents is currently at its all-time high

  • How does NAMS annual cash & cash equivalents rank versus sector peers?

    NAMS annual cash & cash equivalents is higher than 92.03% of companies in Healthcare sector

  • When is NAMS next annual earnings release?

    The next annual earnings release for NAMS is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. NAMS Official Website www.newamsterdampharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1936258/000119312525265796/0001193125-25-265796-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1936258/000095017025027339/0000950170-25-027339-index.htm
  4. NAMS Profile on Yahoo Finance finance.yahoo.com/quote/NAMS
  5. NAMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nams